<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

School of Medicine News and Stories

Neuroscience

Community    Neuroscience    Climate Science    Alzheimer's   

How Air Pollution May Influence Brain Health

The effects of climate change continue to rise across the globe, with increased occurrences of extreme and intense weather. The consequences not only impact the environment, but the changes pose a significant threat to our health.


Author Mara Kalinoski | Publish Date October 04, 2023
Full Story

Community    Neuroscience    Rehabilitation

Fetterman’s Candidacy Brings Attention to Symptoms of and Rehabilitation from Strokes

The widely watched U.S. Senate race between Pennsylvania Lieutenant Governor John Fetterman and Mehmet Oz, MD, has stoked conversation and questions about strokes.

In May, on the way to a campaign event, Fetterman had a stroke that his wife has said she recognized when he began slurring words and the left side of his face began drooping. During his Oct. 25 televised debate with Oz, Fetterman began by addressing “the elephant in the room.”


Author Rachel Sauer | Publish Date November 02, 2022
Full Story

School of Medicine In the News

KKTV

Colorado doctors warning of skyrocketing alcohol use post-pandemic as liver transplants among younger people increase

news outletKKTV
Publish DateFebruary 14, 2024

Colorado doctors say they are concerned about alcohol use after the pandemic, as liver transplants among younger people increase.

More News
Neurology Live

The Evolving Landscape of Treatments for Multiple Sclerosis in 2024: Enrique Alvarez, MD, PhD

news outletNeurology Live
Publish DateFebruary 13, 2024

As the landscape of care evolves in multiple sclerosis (MS), clinicians continue their efforts in optimizing therapeutic approaches for patients. Investigating de-escalation of therapies, which involves transitioning patients from high or moderate efficacy disease-modifying therapies to lower efficacy ones to lower risk of adverse effects, has been a topic of interest.

More News
TCTMD

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

news outletTCTMD
Publish DateFebruary 13, 2024

Cumulative safety data from three trials testing the reversible direct factor XIa inhibitor asundexian in patients at risk for stroke or recurrent cardiovascular events suggest a better bleeding profile compared with apixaban (Eliquis; Bristol Myers Squibb) in a variety of patient types.

More News
CBS News

Flu, COVID, RSV: Colorado doctor says 5% of hospitalized patients have two viruses at the same time

news outletCBS News
Publish DateFebruary 13, 2024

Chances are you or someone you know has gotten sick over the past few weeks or months. 

More News